{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 is covalently modified by SUMO-1 in vitro and in vivo. SUMO-1 was identified as a novel ATXN3-interacting protein by yeast two-hybrid, and co-immunoprecipitation confirmed the interaction. SUMOylation occurs at lysine 166 and increases the stability and cytotoxicity of mutant ATXN3.",
  "functions": [
    {
      "function": "ATXN3 Protein Stability",
      "arrow": "activates",
      "cellular_process": "ATXN3 is post-translationally modified by the covalent attachment of a Small Ubiquitin-like Modifier 1 (SUMO-1) protein, a process known as SUMOylation. A major site for this modification has been identified as lysine 166 (K166) on ATXN3.",
      "effect_description": "The conjugation of SUMO-1 to polyglutamine-expanded ATXN3 enhances the stability of the ATXN3 protein. This increased stability, however, leads to an increase in the cytotoxicity of mutant ATXN3, ultimately promoting apoptosis.",
      "biological_consequence": [
        "SUMO-1 is covalently attached to ATXN3 at lysine 166 -> The stability of polyQ-expanded ATXN3 is increased -> The cytotoxicity of mutant ATXN3 is enhanced -> The rate of apoptosis is increased."
      ],
      "specific_effects": [
        "SUMOylation at K166 partially increases the stability of mutant-type ataxin-3.",
        "SUMO-1 modification of mutant-type ataxin-3 increases the early apoptosis rate of neurons.",
        "SUMOylation does not significantly influence the subcellular localization or the formation of aggregates of mutant-type ataxin-3."
      ],
      "evidence": [
        {
          "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
          "journal": "PLoS One",
          "year": 2013,
          "relevant_quote": "SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis.",
          "pmid": "23382880"
        }
      ],
      "pmids": [
        "23382880"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "ATXN3 is post-translationally modified by the covalent attachment of a Small Ubiquitin-like Modifier 1 (SUMO-1) protein, a process known as SUMOylation. A major site for this modification has been identified as lysine 166 (K166) on ATXN3.",
  "effect": "The conjugation of SUMO-1 to polyglutamine-expanded ATXN3 enhances the stability of the ATXN3 protein. This increased stability, however, leads to an increase in the cytotoxicity of mutant ATXN3, ultimately promoting apoptosis.",
  "summary": "ATXN3 activates SUMO1 to modulate atxn3 protein stability.",
  "evidence": [
    {
      "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
      "journal": "PLoS One",
      "year": 2013,
      "relevant_quote": "SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis."
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- SUMO1:",
  "protein_a": "SUMO1",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-24T07:01:28.108750Z",
  "last_updated": "2025-11-24T07:01:28.108750Z"
}